DCF — RIVERSIDE REGIONAL MEDICAL CENTER
Enterprise Value: $-852.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-852.0M
Enterprise Value
$-285.0M
PV of Cash Flows
$-567.0M
PV of Terminal Value
$-913.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $992.2M | $-44.7M | -4.0% | $-86.7M | $-78.8M |
| Year 2 | $1.0B | $-35.8M | -3.0% | $-79.0M | $-65.3M |
| Year 3 | $1.1B | $-26.3M | -2.0% | $-70.9M | $-53.3M |
| Year 4 | $1.1B | $-21.7M | -2.0% | $-67.6M | $-46.2M |
| Year 5 | $1.1B | $-19.5M | -2.0% | $-66.8M | $-41.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-852.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$963.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.049999999636681475
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5